Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin board meetings
87 filed, newest first. Page 2 of 2.
Jul 2015
May 2015
13 May · Board meeting
Apr 2015
Jan 2015
15 Jan · Board meeting
Interalia to consider and take on record the unaudited financial results for the quarter ended December 31, 2014.
Oct 2014
13 Oct · Board meeting
Inter alia to consider and take on record the unaudited financial results for the quarter ended September 30, 2014
Jul 2014
Apr 2014
Jan 2014
24 Jan · Board meeting
Inter alia, to consider and take on record the unaudited financial results for the quarter and nine-month ended December 31, 2013 and the Board shall consider declaration of interim dividend, if any, for the year ending March 31, 2014.
Oct 2013
15 Oct · Board meeting
Inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2013.
Jul 2013
22 Jul · Board meeting
Inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2013.
Apr 2013
29 Apr · Board meeting
Inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2013 and recommend dividend, if any.
Jan 2013
15 Jan · Board meeting
Inter alia, to consider and take on record unaudited financial results for the quarter ended December 31, 2012.
Oct 2012
23 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 23, 2012 has : (1) Appointed Mr. Dileep C. Choksi as Additional Director (2) Appointed Mr. Dileep C. Choksi as Members of the Audit Committee (3) Appointed Dr. Vijay Kelkar as Chairman of the Investors Grievances Committee and (4) noted and took on record the resignation of Mr. D. K. Contractor from the directorship of the Company on health grounds.8 Oct · Board meeting
Inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2012.
Jul 2012
23 Jul · Board meeting
Inter alia, to Consider and take on record the unaudited financial results for the quarter ended June 30, 2012.
Apr 2012
26 Apr · Board meeting
Inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2012 and recommend dividend, if any.
Jan 2012
11 Jan · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended December 31, 2011.
Oct 2011
14 Oct · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended September 30, 2011.
Jul 2011
12 Jul · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended June 30, 2011.
Apr 2011
21 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2011 and recommend dividend, if any.
Jan 2011
13 Jan · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended December 31, 2010.
Oct 2010
20 Oct · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended September 30, 2010.
Jul 2010
14 Jul · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended June 30, 2010.
Apr 2010
13 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2010 and recommend dividend, if any.
Jan 2010
8 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
12 Oct · Board meeting
Meeting on 26 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
9 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Apr 2009
22 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2009 and recommend dividend, if any.
Jan 2009
12 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
14 Oct · Board meeting
Meeting on 24 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Jul 2008
7 Jul · Board meeting
Meeting on 22 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Apr 2008
25 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2008 and recommend dividend, if any.
Jan 2008
11 Jan · Board meeting
Meeting on 22 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
11 Oct · Board meeting
Meeting on 24 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
9 Jul · Board meeting
Meeting on 19 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
23 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2007 and recommend dividend, if any.
Jan 2007
4 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited financial results for the third quarter covering the period October 1, 2006 to December 31, 2006.